AQEMIA Company
Drug discovery - Pharma 3.0
Investors
Technology:
Artificial Intelligence, Biotechnology, Machine Learning, Pharmaceutical, Quantum Computing
Industry:
AI, Early Drug Development
Headquarters:
Paris, Ile-de-France, France
Founded Date:
2019-06-13
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
3
Total Funding:
31100000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-10-19
Last Funding Type:
Series A
Register and Claim Ownership